Conversely, it was reported that IFN-γ downregulated the differentiation of lung and skin fibroblasts to myofibroblasts [21–25], demonstrating the potential of IFN-γ therapy in patients with idiopathic pulmonary fibrosis or keloids. The gene discussed is IFNG; the disease is keloid.